ACROBiosystems
Private Company
Total funding raised: $65M
Overview
ACROBiosystems is a specialized reagent provider serving the global research and diagnostic markets. The company leverages expertise in protein engineering and production to supply critical tools for drug discovery, assay development, and diagnostic manufacturing. Its position in Germany provides access to a strong European biotech ecosystem, while its global reach suggests a focus on serving international customers. As a supplier to the industry, its success is tied to the overall growth in biomedical R&D spending.
Technology Platform
Advanced recombinant protein expression and purification using mammalian, insect, and bacterial host systems, with expertise in protein conjugation and characterization.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ACROBiosystems competes in a crowded global market for research reagents against large, diversified players like Thermo Fisher Scientific (through brands like Invitrogen) and Abcam, as well as specialized recombinant protein providers such as Sino Biological and R&D Systems (Bio-Techne). Its differentiation hinges on product quality, data depth, and its hybrid geographic operational model.